MicroRNA-based signatures of early and late immune-related adverse events to anti-PD1 treatment.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
Award: G9000109106
OpenAlex ID: W4410810664
